1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Leukocyte 1.2.3 Lymphocytes 1.2.4 Red Blood Cells 1.2.5 Platelets 1.3 Market by Application 1.3.1 Global Hematopoietic Stem Cells (HSCs) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Blood System Diseases 1.3.3 Autoimmune Diseases 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hematopoietic Stem Cells (HSCs) Market Perspective (2016-2027) 2.2 Hematopoietic Stem Cells (HSCs) Growth Trends by Regions 2.2.1 Hematopoietic Stem Cells (HSCs) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Hematopoietic Stem Cells (HSCs) Historic Market Share by Regions (2016-2021) 2.2.3 Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Regions (2022-2027) 2.3 Hematopoietic Stem Cells (HSCs) Industry Dynamic 2.3.1 Hematopoietic Stem Cells (HSCs) Market Trends 2.3.2 Hematopoietic Stem Cells (HSCs) Market Drivers 2.3.3 Hematopoietic Stem Cells (HSCs) Market Challenges 2.3.4 Hematopoietic Stem Cells (HSCs) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hematopoietic Stem Cells (HSCs) Players by Revenue 3.1.1 Global Top Hematopoietic Stem Cells (HSCs) Players by Revenue (2016-2021) 3.1.2 Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Players (2016-2021) 3.2 Global Hematopoietic Stem Cells (HSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hematopoietic Stem Cells (HSCs) Revenue 3.4 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio 3.4.1 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hematopoietic Stem Cells (HSCs) Revenue in 2020 3.5 Hematopoietic Stem Cells (HSCs) Key Players Head office and Area Served 3.6 Key Players Hematopoietic Stem Cells (HSCs) Product Solution and Service 3.7 Date of Enter into Hematopoietic Stem Cells (HSCs) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hematopoietic Stem Cells (HSCs) Breakdown Data by Type 4.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Type (2016-2021) 4.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2022-2027) 5 Hematopoietic Stem Cells (HSCs) Breakdown Data by Application 5.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Application (2016-2021) 5.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Hematopoietic Stem Cells (HSCs) Market Size (2016-2027) 6.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Type 6.2.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2021) 6.2.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2022-2027) 6.2.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2027) 6.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Application 6.3.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2021) 6.3.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2022-2027) 6.3.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2027) 6.4 North America Hematopoietic Stem Cells (HSCs) Market Size by Country 6.4.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2016-2021) 6.4.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Hematopoietic Stem Cells (HSCs) Market Size (2016-2027) 7.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type 7.2.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2021) 7.2.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2022-2027) 7.2.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2027) 7.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application 7.3.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2021) 7.3.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2022-2027) 7.3.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2027) 7.4 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country 7.4.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2016-2021) 7.4.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size (2016-2027) 8.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Type 8.2.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2027) 8.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Application 8.3.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2027) 8.4 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region 8.4.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hematopoietic Stem Cells (HSCs) Market Size (2016-2027) 9.2 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type 9.2.1 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2021) 9.2.2 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2022-2027) 9.2.3 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2027) 9.3 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application 9.3.1 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2021) 9.3.2 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2022-2027) 9.3.3 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2027) 9.4 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country 9.4.1 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2016-2021) 9.4.2 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size (2016-2027) 10.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Type 10.2.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2027) 10.3 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Application 10.3.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2027) 10.4 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country 10.4.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Kite Pharma Inc. 11.1.1 Kite Pharma Inc. Company Details 11.1.2 Kite Pharma Inc. Business Overview 11.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Introduction 11.1.4 Kite Pharma Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.1.5 Kite Pharma Inc. Recent Development 11.2 Thermo Fisher Scientific 11.2.1 Thermo Fisher Scientific Company Details 11.2.2 Thermo Fisher Scientific Business Overview 11.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Introduction 11.2.4 Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.2.5 Thermo Fisher Scientific Recent Development 11.3 PromoCell 11.3.1 PromoCell Company Details 11.3.2 PromoCell Business Overview 11.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Introduction 11.3.4 PromoCell Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.3.5 PromoCell Recent Development 11.4 CellGenix Technologie Transfer GmbH 11.4.1 CellGenix Technologie Transfer GmbH Company Details 11.4.2 CellGenix Technologie Transfer GmbH Business Overview 11.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Introduction 11.4.4 CellGenix Technologie Transfer GmbH Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.4.5 CellGenix Technologie Transfer GmbH Recent Development 11.5 Cesca Therapeutics Inc. 11.5.1 Cesca Therapeutics Inc. Company Details 11.5.2 Cesca Therapeutics Inc. Business Overview 11.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Introduction 11.5.4 Cesca Therapeutics Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.5.5 Cesca Therapeutics Inc. Recent Development 11.6 R&D Systems 11.6.1 R&D Systems Company Details 11.6.2 R&D Systems Business Overview 11.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Introduction 11.6.4 R&D Systems Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.6.5 R&D Systems Recent Development 11.7 Genlantis 11.7.1 Genlantis Company Details 11.7.2 Genlantis Business Overview 11.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Introduction 11.7.4 Genlantis Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.7.5 Genlantis Recent Development 11.8 Lonza Group Ltd. 11.8.1 Lonza Group Ltd. Company Details 11.8.2 Lonza Group Ltd. Business Overview 11.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Introduction 11.8.4 Lonza Group Ltd. Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.8.5 Lonza Group Ltd. Recent Development 11.9 TiGenix N.V. 11.9.1 TiGenix N.V. Company Details 11.9.2 TiGenix N.V. Business Overview 11.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Introduction 11.9.4 TiGenix N.V. Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.9.5 TiGenix N.V. Recent Development 11.10 ScienCell Research Laboratories 11.10.1 ScienCell Research Laboratories Company Details 11.10.2 ScienCell Research Laboratories Business Overview 11.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Introduction 11.10.4 ScienCell Research Laboratories Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.10.5 ScienCell Research Laboratories Recent Development 11.11 China Cord Blood Corporation 11.11.1 China Cord Blood Corporation Company Details 11.11.2 China Cord Blood Corporation Business Overview 11.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Introduction 11.11.4 China Cord Blood Corporation Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.11.5 China Cord Blood Corporation Recent Development 11.12 Vcanbio 11.12.1 Vcanbio Company Details 11.12.2 Vcanbio Business Overview 11.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Introduction 11.12.4 Vcanbio Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.12.5 Vcanbio Recent Development 11.13 Boyalife 11.13.1 Boyalife Company Details 11.13.2 Boyalife Business Overview 11.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Introduction 11.13.4 Boyalife Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.13.5 Boyalife Recent Development 11.14 Beike Biotechnology 11.14.1 Beike Biotechnology Company Details 11.14.2 Beike Biotechnology Business Overview 11.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Introduction 11.14.4 Beike Biotechnology Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) 11.14.5 Beike Biotechnology Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Leukocyte Table 3. Key Players of Lymphocytes Table 4. Key Players of Red Blood Cells Table 5. Key Players of Platelets Table 6. Global Hematopoietic Stem Cells (HSCs) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Hematopoietic Stem Cells (HSCs) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Hematopoietic Stem Cells (HSCs) Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Hematopoietic Stem Cells (HSCs) Market Share by Regions (2016-2021) Table 10. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Hematopoietic Stem Cells (HSCs) Market Share by Regions (2022-2027) Table 12. Hematopoietic Stem Cells (HSCs) Market Trends Table 13. Hematopoietic Stem Cells (HSCs) Market Drivers Table 14. Hematopoietic Stem Cells (HSCs) Market Challenges Table 15. Hematopoietic Stem Cells (HSCs) Market Restraints Table 16. Global Hematopoietic Stem Cells (HSCs) Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Hematopoietic Stem Cells (HSCs) Market Share by Players (2016-2021) Table 18. Global Top Hematopoietic Stem Cells (HSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2020) Table 19. Ranking of Global Top Hematopoietic Stem Cells (HSCs) Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Hematopoietic Stem Cells (HSCs) Product Solution and Service Table 23. Date of Enter into Hematopoietic Stem Cells (HSCs) Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2021) (US$ Million) Table 26. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2016-2021) Table 27. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Hematopoietic Stem Cells (HSCs) Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Application (2016-2021) Table 31. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2021) (US$ Million) Table 34. North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2021) (US$ Million) Table 36. North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2022-2027) & (US$ Million) Table 63. Kite Pharma Inc. Company Details Table 64. Kite Pharma Inc. Business Overview Table 65. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Product Table 66. Kite Pharma Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 67. Kite Pharma Inc. Recent Development Table 68. Thermo Fisher Scientific Company Details Table 69. Thermo Fisher Scientific Business Overview Table 70. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product Table 71. Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 72. Thermo Fisher Scientific Recent Development Table 73. PromoCell Company Details Table 74. PromoCell Business Overview Table 75. PromoCell Hematopoietic Stem Cells (HSCs) Product Table 76. PromoCell Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 77. PromoCell Recent Development Table 78. CellGenix Technologie Transfer GmbH Company Details Table 79. CellGenix Technologie Transfer GmbH Business Overview Table 80. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product Table 81. CellGenix Technologie Transfer GmbH Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 82. CellGenix Technologie Transfer GmbH Recent Development Table 83. Cesca Therapeutics Inc. Company Details Table 84. Cesca Therapeutics Inc. Business Overview Table 85. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Product Table 86. Cesca Therapeutics Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 87. Cesca Therapeutics Inc. Recent Development Table 88. R&D Systems Company Details Table 89. R&D Systems Business Overview Table 90. R&D Systems Hematopoietic Stem Cells (HSCs) Product Table 91. R&D Systems Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 92. R&D Systems Recent Development Table 93. Genlantis Company Details Table 94. Genlantis Business Overview Table 95. Genlantis Hematopoietic Stem Cells (HSCs) Product Table 96. Genlantis Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 97. Genlantis Recent Development Table 98. Lonza Group Ltd. Company Details Table 99. Lonza Group Ltd. Business Overview Table 100. Lonza Group Ltd. Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 101. Lonza Group Ltd. Recent Development Table 102. TiGenix N.V. Company Details Table 103. TiGenix N.V. Business Overview Table 104. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Product Table 105. TiGenix N.V. Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 106. TiGenix N.V. Recent Development Table 107. ScienCell Research Laboratories Company Details Table 108. ScienCell Research Laboratories Business Overview Table 109. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product Table 110. ScienCell Research Laboratories Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 111. ScienCell Research Laboratories Recent Development Table 112. China Cord Blood Corporation Company Details Table 113. China Cord Blood Corporation Business Overview Table 114. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product Table 115. China Cord Blood Corporation Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 116. China Cord Blood Corporation Recent Development Table 117. Vcanbio Company Details Table 118. Vcanbio Business Overview Table 119. Vcanbio Hematopoietic Stem Cells (HSCs) Product Table 120. Vcanbio Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 121. Vcanbio Recent Development Table 122. Boyalife Company Details Table 123. Boyalife Business Overview Table 124. Boyalife Hematopoietic Stem Cells (HSCs) Product Table 125. Boyalife Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 126. Boyalife Recent Development Table 127. Beike Biotechnology Company Details Table 128. Beike Biotechnology Business Overview Table 129. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product Table 130. Beike Biotechnology Revenue in Hematopoietic Stem Cells (HSCs) Business (2016-2021) & (US$ Million) Table 131. Beike Biotechnology Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global Hematopoietic Stem Cells (HSCs) Market Share by Type: 2020 VS 2027 Figure 2. Leukocyte Features Figure 3. Lymphocytes Features Figure 4. Red Blood Cells Features Figure 5. Platelets Features Figure 6. Global Hematopoietic Stem Cells (HSCs) Market Share by Application: 2020 VS 2027 Figure 7. Blood System Diseases Case Studies Figure 8. Autoimmune Diseases Case Studies Figure 9. Other Case Studies Figure 10. Hematopoietic Stem Cells (HSCs) Report Years Considered Figure 11. Global Hematopoietic Stem Cells (HSCs) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Hematopoietic Stem Cells (HSCs) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Hematopoietic Stem Cells (HSCs) Market Share by Regions: 2020 VS 2027 Figure 14. Global Hematopoietic Stem Cells (HSCs) Market Share by Regions (2022-2027) Figure 15. Global Hematopoietic Stem Cells (HSCs) Market Share by Players in 2020 Figure 16. Global Top Hematopoietic Stem Cells (HSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue in 2020 Figure 18. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2016-2021) Figure 19. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2022-2027) Figure 20. North America Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Hematopoietic Stem Cells (HSCs) Market Share by Type (2016-2027) Figure 22. North America Hematopoietic Stem Cells (HSCs) Market Share by Application (2016-2027) Figure 23. North America Hematopoietic Stem Cells (HSCs) Market Share by Country (2016-2027) Figure 24. United States Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Hematopoietic Stem Cells (HSCs) Market Share by Type (2016-2027) Figure 28. Europe Hematopoietic Stem Cells (HSCs) Market Share by Application (2016-2027) Figure 29. Europe Hematopoietic Stem Cells (HSCs) Market Share by Country (2016-2027) Figure 30. Germany Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Share by Type (2016-2027) Figure 38. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Share by Application (2016-2027) Figure 39. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Share by Region (2016-2027) Figure 40. China Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Hematopoietic Stem Cells (HSCs) Market Share by Type (2016-2027) Figure 48. Latin America Hematopoietic Stem Cells (HSCs) Market Share by Application (2016-2027) Figure 49. Latin America Hematopoietic Stem Cells (HSCs) Market Share by Country (2016-2027) Figure 50. Mexico Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Share by Type (2016-2027) Figure 54. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Share by Application (2016-2027) Figure 55. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Share by Country (2016-2027) Figure 56. Turkey Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Kite Pharma Inc. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 61. PromoCell Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 62. CellGenix Technologie Transfer GmbH Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 63. Cesca Therapeutics Inc. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 64. R&D Systems Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 65. Genlantis Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 66. Lonza Group Ltd. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 67. TiGenix N.V. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 68. ScienCell Research Laboratories Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 69. China Cord Blood Corporation Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 70. Vcanbio Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 71. Boyalife Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 72. Beike Biotechnology Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Kite Pharma Inc. Thermo Fisher Scientific PromoCell CellGenix Technologie Transfer GmbH Cesca Therapeutics Inc. R&D Systems Genlantis Lonza Group Ltd. TiGenix N.V. ScienCell Research Laboratories China Cord Blood Corporation Vcanbio Boyalife Beike Biotechnology